Ads
related to: inotropic agents for heart failure- Heart Failure Treatment
Download Our Free Treatment Guide.
Discover Options for Heart Failure.
- Heart Failure Stages
Access Our Heart Failure Guide.
Learn About Heart Failure Stages.
- Heart Failure Symptoms
Access a Free Treatment Guide.
Understand Heart Failure Symptoms.
- Living With Heart Failure
Access a Heart Failure Guide.
Learn About Treatment Options.
- Heart Failure Treatment
Search results
Results from the WOW.Com Content Network
Cardiotonic agents are typically employed as short-term and non-routine therapies for heart failure patients. [71] They are specifically reserved for those with contractile dysfunction in the left ventricles (lower chambers of the heart), low cardiac output, and low blood pressure, placing them at risk of inadequate organ perfusion. [72]
Negative inotropic agents decrease myocardial contractility and are used to decrease cardiac workload in conditions such as angina. While negative inotropism may precipitate or exacerbate heart failure in the short term, certain beta blockers (e.g. carvedilol , bisoprolol and metoprolol ) have been believed to reduce long-term morbidity and ...
The inotropic agent dobutamine is advised only in the short-term use of acutely decompensated heart failure, and has no other uses. [ 13 ] Phosphodiesterase inhibitors such as milrinone are sometimes utilized in severe cardiomyopathy.
PDE3 inhibitors are indicated as inotropics for the therapy of acute heart failure if catecholamines are ineffective. [2] Well controlled studies have shown that these drugs generally increase mortality, [3] when used for the therapy of acute heart failure, so they have to be applied under close observation. [1]
The effects of amrinone vary widely with species and experimental condition; therefore, its inotropic effects are variable. [3] A loss in sensitivity to phosphodiesterase 3 inhibitors, including amrinone, has been observed in end stage heart failure in humans; other treatment options may be more useful for improvement in these stages. [3]
Dobutamine can be used in cases of congestive heart failure to increase cardiac output. It is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility, which could be the result of either organic heart disease or cardiac surgical ...
Ads
related to: inotropic agents for heart failure